(19)
(11) EP 1 784 396 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.04.2011 Bulletin 2011/16

(45) Mention of the grant of the patent:
22.12.2010 Bulletin 2010/51

(21) Application number: 05782821.2

(22) Date of filing: 15.08.2005
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
A61K 31/4439(2006.01)
 C07D 401/04(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/IB2005/002695
(87) International publication number:
WO 2006/021881 (02.03.2006 Gazette 2006/09)

(54)

PYRAZOLE-SUBSTITUTED AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS

PYRAZOL-SUBSTITUIERTE AMINOHETEROARYLVERBINDUNGEN ALS PROTEINKINASEHEMMER

COMPOSES AMINOHETEROARYLE A SUBSTITUTION PYRAZOLE SERVANT D'INHIBITEURS DE PROTEINE KINASE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 26.08.2004 US 605244 P
14.06.2005 US 690803 P

(43) Date of publication of application:
16.05.2007 Bulletin 2007/20

(73) Proprietor: Pfizer Inc.
New York, NY 10017 (US)

(72) Inventors:
  • CUI, Jingrong Jean, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • FUNK, Lee Andrew, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • JIA, Lei, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • KUNG, Pei-Pei, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • MENG, Jerry Jialun, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • NAMBU, Mitchell David, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • PAIRISH, Mason Alan, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • SHEN, Hong, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • TRAN-DUBE, Michelle Bich, Pfizer Global R&D
    San Diego, CA 92121 (US)

(74) Representative: Nevant, Marc et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)


(56) References cited: : 
WO-A-03/066608
WO-A-2004/076412
 WO-A-2004/013091
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).